Hanall Biopharma Market Cap

Hanall Biopharma has a market cap or net worth of 1.30 trillion as of June 27, 2025. Its market cap has decreased by -30.52% in one year.

Market Cap

1.30T

Enterprise Value

1.29T

Revenue

141.00B

Ranking

n/a

PE Ratio

n/a

Stock Price

24,750.00

Market Cap Chart

Since August 30, 1995, Hanall Biopharma's market cap has increased from 26.30B to 1.30T, an increase of 4,848.73%. That is a compound annual growth rate of 13.98%.

Market Cap History

Date	Market Cap	% Change
Jun 18, 2025	1,301.48B	-33.60%
Dec 30, 2024	1,959.95B	-12.72%
Dec 28, 2023	2,245.71B	148.89%
Dec 29, 2022	902.29B	-16.29%
Dec 30, 2021	1,077.89B	-43.84%
Dec 30, 2020	1,919.22B	3.31%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	71.46T
Celltrion	35.49T
ALTEOGEN	20.84T
Yuhan	7,589.05B
SK Biopharmaceuticals	7,236.14B
HLB Co., Ltd.	6,512.41B
PharmaResearch	4,992.23B
Peptron	4,741.01B

Market Cap Rankings